Question
Can licensing our data raise cash without taking on debt or giving up equity?
On this page
- Is this a loan, an investment or a sale?
- How does it compare with a bank loan, an investor or selling the company?
- How much would it bring in, and when?
- Can I count on it the way I’d count on a loan?
- Has anyone used license money to pay down debt?
- Does my bank or an investor get a say, or a claim on the money?
- What does licensing take off the table later?
- When is a loan, an investor or a sale the better tool?
Yes. A data license can pay your company without borrowing or issuing shares. In exchange, you grant rights to specified records. The amount and payment trigger depend on the agreement; a published range is a starting point for discussion.
Is this a loan, an investment or a sale?
For the license programs below, it is payment for defined rights: the buyer gets defined rights to use a copy of your records, and your company keeps the originals and its shares and takes on no debt. Polyshares’ terms table puts it as “A license to defined operational data. Non-dilutive. No equity, no debt.” The outright purchases Data Licensing Report has found are of closing or bankrupt companies’ records; Am I selling my data or licensing it? explains when a deal is a sale.
“Non-dilutive” describes your shares, not your records. Each of Polyshares’ four published case studies is a “Perpetual exclusive license to the operational record”, so exclusivity is part of what those sellers accepted. The agreement defines the covered records, permitted uses and any exceptions; the case-study label alone does not settle every retained right. What a license takes instead of equity is set by its scope, length, exclusivity and the promises you make about your rights to the data; the same page explains each term. How the payment is taxed is a separate question, covered in Is money from licensing our company data taxed as income or capital gain?
How does it compare with a bank loan, an investor or selling the company?
Each one trades something different for the cash.
| Bank or SBA loan | Equity investor | Selling the company | Licensing records | |
|---|---|---|---|---|
| What you receive | A set amount, repaid with interest | Cash in return for a share of the company | The price of the company | A fee, milestones, or a share of each resale |
| What you give up | No ownership; the loan may be secured on company assets | Some ownership and control; the SBA says venture investors invest “in return for equity, rather than debt” | The company | Rights to a copy of the records, on the license’s terms |
| What you owe afterwards | Repayments and the loan’s covenants | The investor’s rights under the company or shareholder agreement | What the purchase agreement keeps you to | The license’s promises: scope, any exclusivity or future deliveries, warranties |
| When the amount is certain | When final loan terms are agreed; funding follows closing conditions | When binding terms are agreed; funding follows closing conditions | When binding terms are agreed, subject to adjustments and closing conditions | When the price is agreed in writing; payment follows its approval, delivery, acceptance or resale conditions |
A license raises cash against records rather than shares or a repayment promise. The useful comparison is the cash you receive, the rights or obligations you accept, and the conditions that still stand between agreement and payment.
How much would it bring in, and when?
As of October 2026, the providers below publish these figures and terms. Each is the provider’s own statement, not an average and not a completed deal:
| Provider | Published amount | How it pays | Published timing |
|---|---|---|---|
| Polyshares | $100K to $2M, and above for large records | One amount per deal in each published case study | Net 30 to 60 days once the data is approved, shared and anonymized |
| Corpus | $100K to $500K at 25 to 100 employees, rising to $1.8M to $2M+ at 2,000+; it says the figures reflect closed engagements | “No fees, no revenue share, no ongoing obligation”; larger deals can be split into an upfront and a delivery tranche | Days 40 to 60 of its schedule, counted from intake; its get-paid page says 30 to 60 days after delivery |
| Mercor | Priced by dataset | A wire “upon delivery of the anonymized dataset to the buyer” | Typically 2 to 4 weeks after the signed agreement |
| Telegraph Lab (affiliated with this site) | $100K to $4M, subject to data review and agreed terms | Milestones set in the signed agreement | Not published |
| Handshake AI | $100K to $4M | Not published | Not published |
| Appen | Quoted per partnership | “Payment is on acceptance rather than submission.” | Not published |
| Replay | $10K to $100K at 20 to 50 employees; $100K to $1M at 50 to 250 | Upfront cash plus a perpetual revenue share | Not published |
| Troveo | Says AI labs and startups are paying six figures for company exports; gives no seller-payout range | A share of revenue on every sale | No business-data payment deadline on that page |
The figures describe different offers, including one-time fees and upfront payments with later revenue shares. Do not combine them into a market price. What moves a company within a provider’s range is covered in How much is my company’s data worth?, and each step from first call to wire in How long until I get paid?
Can I count on it the way I’d count on a loan?
An agreed license can be a funding source, but a conditional offer still has conditions to meet. Four points determine when a figure becomes usable cash:
- The first number is an estimate. Nyne’s estimator says its figure “is indicative and not an offer”. Review precedes pricing; Polyshares says “We do not pay for a record we have not seen, so the review comes first.” How data licensing offers work explains the two stages.
- Review can lower the number, or end it. Nyne says “Final value is determined by data quality, volume, rights, and the outcome of due diligence.” A buyer that reviews your records can also make no offer.
- Payment waits on an event, not a date. The examples above include payment on approval, delivery or acceptance. Your agreement should define the standard, who accepts the records and the payment deadline.
- A revenue share depends on resale. Troveo describes a share of revenue on every sale, with terms set in the agreement; that business-data page gives no payment deadline. Replay describes an upfront payment plus a perpetual revenue share but gives no share percentage or payment schedule on its homepage (checked October 6, 2026).
So, for planning:
- If you need the money by a fixed date, such as a loan maturity or a purchase, budget only an upfront amount from a firm offer whose agreement says when payment follows acceptance, and keep your other funding in place until the wire arrives.
- If the offer is a revenue share, plan around the upfront part, if there is one, and assess later payments against the resale terms.
- If the figure came from a calculator, or before anyone saw a sample, it is not yet money you can budget.
Has anyone used license money to pay down debt?
Yes, in one case. Telegraph Lab, which is commercially affiliated with Data Licensing Report, has described one transaction to Data Licensing Report: for an online retailer, three buyers were approached and two made offers, and the owner received $300,000 within two weeks of the first conversation and used it to repay high-interest debt. That is a single transaction, not an average or a typical timeline, and Telegraph Lab publishes no duration for the steps of its process (checked October 2026).
Before you plan the same, read the loan agreement as well as the license: the lender may have a say over the license, and a claim on what it pays.
Does my bank or an investor get a say, or a claim on the money?
They may have both, depending on documents you already hold. Three things to check, with your lawyer:
- Consent. Loan and security agreements can bar licensing the collateral without the lender’s approval, and an investor’s company or shareholder agreement can list decisions that need its consent. My partners or board need to approve sets out which documents to read, including the SBA disaster-loan wording, and how to record the approval.
- A claim on the payment. Under the Uniform Commercial Code’s model text, “proceeds” of collateral include “whatever is acquired upon the sale, lease, license, exchange, or other disposition of collateral” (§9-102(a)(64)), and a lender’s security interest “attaches to any identifiable proceeds of collateral” (§9-315(a)(2)). If your records fall within a lien on general intangibles, the license fee may be the lender’s collateral too.
- The lien itself. The same section says a security interest continues in collateral notwithstanding a license “unless the secured party authorized the disposition free of the security interest” (§9-315(a)(1)). If your lawyer finds the records are collateral, that is one more reason to get the lender’s consent in writing before signing.
Whether your records are collateral, and what your loan says about license income, are questions for your lawyer to answer from your own security agreement, before the money is spent.
What does licensing take off the table later?
Possibly the right to license the same records again, and some room in a later sale. Three things decide it: exclusivity, future deliveries, and how the license sits in a sale of your company.
- Exclusivity. An exclusive, perpetual license can prevent further licenses within its agreed scope. A non-exclusive license, such as Corpus’s “single non-exclusive data licensing agreement”, leaves you free to license the same records again.
- Future deliveries. Replay says “New data you produce follows the same path, and continues to pay you.” That describes a recurring opportunity. Whether future deliveries are required, and for how long, is a question for the agreement.
- A later sale of the company. A buyer of your company will need to assess the license’s scope, duration and transfer terms; a one-time payment may be treated as non-recurring when earnings are reviewed. If we license our data now, does it affect selling the company later? covers both.
When is a loan, an investor or a sale the better tool?
When its funding terms better match your amount, timing and purpose. Each route has approval and closing conditions.
- If you need a known amount on a known date, compare an approved loan’s funding schedule with the license’s remaining conditions. The SBA’s 7(a) program lends up to $5 million for uses that include short- and long-term working capital and refinancing current business debt (checked October 6, 2026).
- If the need repeats, such as seasonal working capital, a credit line can be drawn again; a license pays for the records it covers, and pays again only through a revenue share or future deliveries.
- If you need more than the published ranges, or a partner for growth, an investor can put in an agreed amount, at the cost the SBA describes for venture capital: “be prepared to give up some portion of both control and ownership of your company in exchange for funding”.
- If you want out of the business, selling the company is the tool. A license signed first becomes part of that sale.
- If the records cannot be licensed, because of client contracts, privacy or a lender’s refusal, that licensing proposal cannot fund the business; Is it legal to sell company emails and records? lists what to check.
Licensing fits when the company has records a buyer wants, can let them go on terms it accepts, and can wait for review and delivery. The tools also combine: license money can reduce a loan, as in the retailer case above. The guide covers the licensing process from the start.
Providers named on this page
Get offers
Find the next step for your company’s data.
- No records or exports needed to apply
- Free for businesses
- Your company profile comes to our team for review